Enanta Pharmaceuticals, Inc (ENTA) is a publicly traded Healthcare sector company. As of October 13, 2026, ENTA trades at $12.37 with a market cap of $364.07M and a P/E ratio of -5.06. ENTA moved +0.56% today. Year to date, ENTA is -22.00%; over the trailing twelve months it is +11.62%. Its 52-week range spans $4.09 to $17.15. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces ENTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover ENTA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $20.00.
| Metric | Value |
|---|---|
| Price | $12.37 |
| Market Cap | $364.07M |
| P/E Ratio | -5.06 |
| EPS | $-2.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.15 |
| 52-Week Low | $4.09 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $65.26M |
| Net Income | $-63.23M |
| Gross Margin | 0.00% |
1 analysts cover ENTA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.